Delivery Order SPE2DB20D1100-SPE2DB24FA2M2
Award Date 2/14/24
Potential Completion Date 2/15/24
Potential Value $13K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award is a delivery order (SPE2DB20D3104|SPE2DB24FV4Q1) issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,379.98 firm fixed-price contract is for the supply of XULANE 150-35 MCG/DAY PATCH 3S, a pharmaceutical product, with a completion date of January 19, 2024. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant...
- This federal contract award, valued at $7,975.32, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is a Delivery Order (DO) under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. The contract covers the delivery of XULANE 150-35 MCG/DAY PATCH 3S, a pharmaceutical product, to support military healthcare...
- This federal contract award, valued at $2,854.52, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is a delivery order for XULANE 150-35 MCG/DAY PATCH 3S, a medical product, with a completion date of December 6, 2023. The contract is a Firm Fixed Price arrangement and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp,...
- This federal contract award, with ID SPE2DB22D1002|SPE2DB24FKYH0, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $2,347.00 firm fixed-price delivery order is for the supply of XULANE 150-35 MCG/DAY PATCH 3S, a pharmaceutical product. This award is not designated with any set-aside requirements, indicating open competition. The contract has an ultimate completion date of February 22, 2024 and was awarded on February 21, 2024....
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract, valued at $1,954.31, is for the delivery of the pharmaceutical product XULANE 150-35 MCG/DAY PATCH 3S. The award is a Delivery Order contract with a Firm Fixed Price pricing type, and the ultimate completion date is November 17, 2023. This contract does not have a set-aside designation, indicating it was awarded through full...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor, Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $5,491.50 delivery order is for the pharmaceutical product XULANE 150-35 MCG/DAY PATCH 3S. The award is not designated with any set-aside requirements, indicating open competition. Amerisourcebergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $2,632.16 fixed-price delivery order is for the pharmaceutical product XULANE 150-35 MCG/DAY PATCH 3S. The award has an ultimate completion date of May 6, 2024. This award is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, which serves as the primary vehicle...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,637.57 firm fixed-price delivery order is for the supply of XULANE 150-35 MCG/DAY PATCH 3S, a medical product used in healthcare. The contract has a completion date of June 6, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This federal contract award, valued at $2,863.13, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The delivery order covers the supply of the pharmaceutical product XULANE 150-35 MCG/DAY PATCH 3S. This contract does not have a set-aside designation, indicating it was competitively awarded. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that plays a critical role in supplying medical products to federal government...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $3,441.01 delivery order is for the pharmaceutical product "XULANE 150-35 MCG/DAY PATCH 3S" and has an ultimate completion date of January 18, 2022. Amerisourcebergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a...